AbbVie Inc. (4AB.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 409.2B |
| Enterprise Value | 473.04B |
| P/E Ratio | 79.97 |
| PEG Ratio | 1.17 |
| Price/Sales Ratio | 7.79 |
| Price/Book Ratio | -84.7 |
| Enterprise/Revenue | 8.79 |
| Enterprise/EBITDA | 26.71 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.29 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | -1.36 |
Income Statement
| Revenue | 61.16B |
| Revenue/Share | 36.36 |
| Gross Profit | 42.96B |
| EBITDA | 17.63B |
| Net Income | 4.23B |
| Diluted EPS | 2.36 |
Balance Sheet
| Total Cash | 6.57B |
| Total Cash/Share | 3.71 |
| Total Debt | 70.88B |
| Total Debt/Equity | -11.93 |
| Current Ratio | 0.81 |
| Book Value Per Share | -3.31 |
Price History
| 52-Week Change | 27.74 |
| 52-Week High | 259.6 |
| 52-Week Low | 162.85 |
| Moving Average 50 Days | 231.31 |
| Moving Average 200 Days | 203.28 |
Statistics
| Average Volume | 592 |
| Shares Outstanding | 1.77B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 6.92 |
| Trailing Annual Dividend Yield | 2.44 |
| Payout Ratio | 1.9 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
